Ellagic acid reduces adipogenesis through inhibition of differentiation-prevention of the induction of rb phosphorylation in 3T3-L1 Adipocytes

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wang, Lifeng ^a   Li, Linlin ^a   Ran, Xinjian ^a   Long, Mei ^a   Zhang, Minfang ^a   Tao, Yicun ^a   Luo, Xin ^a   Wang, Ye ^a   Ma, Xiaoli ^a   Halmurati, Upur ^a   Mao, Xinmin ^a   Ren, Jun ^b  

^a XINJIANG MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF WYOMING COLLEGE OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; ELLAGIC ACID; RETINOBLASTOMA PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; DNA BINDING; FLUORESCENCE ACTIVATED CELL SORTING; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; LIPID STORAGE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 84888607916     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/287534     Document Type: Article

References (37)

1. Patti M., Rehashing endocannabinoid antagonists: can we selectively target the periphery to safely treat obesity and type 2 diabetes? Journal of Clinical Investigation 2010 120 8 2646 2648 2-s2.0-77955289085 10.1172/JCI44099
2. Pérez M. R., Medina-Gómez G., Obesity, adipogenesis and insulin resistance. Endocrinologia y Nutricion 2011 58 7 360 369 2-s2.0-80052262782 10.1016/j.endonu.2011.05.008
3. Tang Q. Q., Lane M. D., Adipogenesis: from stem cell to adipocyte. Annual Review of Biochemistry 2012 81 715 736 10.1146/annurev-biochem-052110-115718
4. Hilton C., Neville M. J., Karpe F., MicroRNAs in adipose tissue: their role in adipogenesis and obesity. International Journal of Obesity 2013 37 3 325 332 2-s2.0-84859930281 10.1038/ijo.2012.59
5. Tanabe Y., Nakayama K., Mechanical stretching inhibits adipocyte differentiation of 3T3-L1 cells: the molecular mechanism and pharmacological regulation. Nihon Yakurigaku Zasshi 2004 124 5 337 344 2-s2.0-8844255469 10.1254/fpj.124.337 (Pubitemid 39536348)
6. Tang Q. Q., Otto T. C., Lane M. D., Mitotic clonal expansion: a synchronous process required for adipogenesis. Proceedings of the National Academy of Sciences of the United States of America 2003 100 1 44 49 2-s2.0-0037422569 10.1073/pnas.0137044100 (Pubitemid 36078027)
7. Ide J., Gagnon A., Molgat A. S. D., Landry A., Foster C., Sorisky A., Macrophage-conditioned medium inhibits the activation of cyclin-dependent kinase 2 by adipogenic inducers in 3T3-L1 preadipocytes. Journal of Cellular Physiology 2011 226 9 2297 2306 2-s2.0-79958719009 10.1002/jcp.22566
8. Cole K. A., Harmon A. W., Harp J. B., Patel Y. M., Rb regulates C/EBP β -DNA-binding activity during 3T3-L1 adipogenesis. The American Journal of Physiology-Cell Physiology 2004 286 2 C349 C354 2-s2.0-0742305441 (Pubitemid 38146358)
9. Cuccioloni M., Mozzicafreddo M., Bonfili L., Cecarini V., Eleuteri A. M., Angeletti M., Natural occurring polyphenols as template for drug design. Focus on serine proteases. Chemical Biology and Drug Design 2009 74 1 1 15 2-s2.0-67650492230 10.1111/j.1747-0285.2009.00836.x
10. González-Sarrías A., Espín J., Tomás- Barberán F. A., García-Conesa M., Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins. Molecular Nutrition and Food Research 2009 53 6 686 698 2-s2.0-67651022312 10.1002/mnfr.200800150
11. Narayanan B. A., Re G. G., IGF-II down regulation associated cell cycle arrest in colon cancer cells exposed to phenolic antioxidant ellagic acid. Anticancer Research 2001 21 1 359 364 2-s2.0-0035059765 (Pubitemid 32267668)
12. Vanella L., Barbagallo I., Acquaviva R., Di Giacomo C., Cardile V., Abraham N. G., Sorrenti V., Ellagic acid: cytodifferentiating and antiproliferative effects in human prostatic cancer cell lines. Current Pharmaceutical Design 2013 19 15 2728 2736 10.2174/1381612811319150008
13. Panchal S. K., Ward L., Brown L., Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. European Journal of Nutrition 2013 52 2 559 568 2-s2.0-84860138826 10.1007/s00394-012- 0358-9
14. Makino-Wakagi Y., Yoshimura Y., Uzawa Y., Zaima N., Moriyama T., Kawamura Y., Ellagic acid in pomegranate suppresses resistin secretion by a novel regulatory mechanism involving the degradation of intracellular resistin protein in adipocytes. Biochemical and Biophysical Research Communications 2012 417 2 880 885 2-s2.0-84855825656 10.1016/j.bbrc.2011.12.067
15. Yarmo M. N., Landry A., Molgat A. S. D., Gagnon A., Sorisky A., Macrophage-conditioned medium inhibits differentiation-induced Rb phosphorylation in 3T3-L1 preadipocytes. Experimental Cell Research 2009 315 3 411 418 2-s2.0-58149483492 10.1016/j.yexcr.2008.10.036
16. Drira R., Chen S., Sakamoto K., Oleuropein and hydroxytyrosol inhibit adipocyte differentiation in 3 T3-L1 cells. Life Sciences 2011 89 19-20 708 716 2-s2.0-80054988630 10.1016/j.lfs.2011.08.012
17. Wang L., Li L., Ran X., Long M., Zhang M., Tao Y., Luo X., Wang Y., Jiao Y., Mao X., Ren J., Lipopolysaccharides reduce adipogenesis in 3T3-L1 adipocytes through activation of NF- B pathway and downregulation of AMPK expression. Cardiovascular Toxicology 2013 10.1007/s12012-013-9214-2
18. Tang Q. Q., Grønborg M., Huang H., Kim J., Otto T. C., Pandey A., Lane M. D., Sequential phosphorylation of CCAAT enhancer-binding protein β by MAPK and glycogen synthase kinase 3 β is required for adipogenesis. Proceedings of the National Academy of Sciences of the United States of America 2005 102 28 9766 9771 2-s2.0-22244479353 10.1073/pnas.0503891102 (Pubitemid 40993643)
19. Guo L., Li X., Huang J. X., Huang H. Y., Zhang Y. Y., Qian S. W., Zhu H., Zhang Y. D., Liu Y., Liu Y., Wang K. K., Tang Q. Q., Histone demethylase Kdm4b functions as a co-factor of C/EBP β to promote mitotic clonal expansion during differentiation of 3T3-L1 preadipocytes. Cell Death and Differentiation 2012 19 12 1917 1927 10.1038/cdd.2012.75
20. Hsu C. L., Yen G. C., Effects of capsaicin on induction of apoptosis and inhibition of adipogenesis in 3T3-L1 cells. Journal of Agricultural and Food Chemistry 2007 55 5 1730 1736 2-s2.0-33947596710 10.1021/jf062912b (Pubitemid 46479577)
21. Farmer S. R., Transcriptional control of adipocyte formation. Cell Metabolism 2006 4 4 263 273 2-s2.0-33748942837 10.1016/j.cmet.2006.07.001 (Pubitemid 44430910)
22. Mayer M. A., Höcht C., Puyó A., Taira C. A., Recent advances in obesity pharmacotherapy. Current Clinical Pharmacology 2009 4 1 53 61
23. 2+-ATPase, ameliorate diabetes mellitus-induced diastolic dysfunction in isolated murine ventricular myocardia. European Journal of Pharmacology 2013 706 1-3 48 55 10.1016/j.ejphar.2013.02.045
24. Hagiwara Y., Kasukabe T., Kaneko Y., Niitsu N., Okabe-Kado J., Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells. International Journal of Hematology 2010 92 1 136 143 2-s2.0-77955176136 10.1007/s12185-010-0627-4
25. Mejia-Meza E. I., Yáñez J. A., Remsberg C. M., Takemoto J. K., Davies N. M., Rasco B., Clary C., Effect of dehydration on raspberries: polyphenol and anthocyanin retention, antioxidant capacity, and antiadipogenic activity. Journal of Food Science 2010 75 1 H5 H12 2-s2.0-74249114863 10.1111/j.1750-3841.2009.01383.x
26. Rogerio A. P., Fontanari C., Borducchi E., Keller A. C., Russo M., Soares E. G., Albuquerque D. A., Faccioli L. H., Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma. European Journal of Pharmacology 2008 580 1-2 262 270 2-s2.0-37849023783 10.1016/j.ejphar.2007. 10.034
27. Falsaperla M., Morgia G., Tartarone A., Ardito R., Romano G., Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate. European Urology 2005 47 4 449 454 2-s2.0-14844355240 10.1016/j.eururo.2004.12.001 (Pubitemid 40357886)
28. Mishra S., Vinayak M., Ellagic acid checks lymphoma promotion via regulation of PKC signaling pathway. Molecular Biology Reports 2013 40 2 1417 1428 10.1007/s11033-012-2185-8
29. Chang W. C., Yu Y., Chiang S., Tseng C., Ellagic acid suppresses oxidised low-density lipoprotein-induced aortic smooth muscle cell proliferation: studies on the activation of extracellular signal-regulated kinase 1/2 and proliferating cell nuclear antigen expression. The British Journal of Nutrition 2008 99 4 709 714 2-s2.0-40449111366 10.1017/S0007114507831734 (Pubitemid 351351623)
30. Li T. M., Chen G., Su C., Lin J., Yeh C., Cheng K., Chung J., Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Research 2005 25 2 971 979 2-s2.0-17444408529 (Pubitemid 40546871)
31. Losso J. N., Bansode R. R., Trappey A. II, Bawadi H. A., Truax R., In vitro anti-proliferative activities of ellagic acid. Journal of Nutritional Biochemistry 2004 15 11 672 678 2-s2.0-10044262012 10.1016/j.jnutbio.2004.06.004 (Pubitemid 39611365)
32. Mertens-Talcott S. U., Talcott S. T., Percival S. S., Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. Journal of Nutrition 2003 133 8 2669 2674 2-s2.0-0041709308 (Pubitemid 36935989)
33. Ahn J., Lee H., Kim S., Ha T., Resveratrol inhibits TNF-induced changes of adipokines in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 2007 364 4 972 977 2-s2.0-36048974865 10.1016/j.bbrc.2007.10.109 (Pubitemid 350090002)
34. Mitterberger M. C., Zwerschke W., Mechanisms of resveratrol-induced inhibition of clonal expansion and terminal adipogenic differentiation in 3T3-L1 preadipocytes. Journals of Gerontology A 2013 10.1093/gerona/glt019
35. Nevins J. R., The Rb/E2F pathway and cancer. Human Molecular Genetics 2001 10 7 699 703 2-s2.0-0035063183 (Pubitemid 32331578)
36. Lundberg A. S., Weinberg R. A., Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Molecular and Cellular Biology 1998 18 2 753 761 2-s2.0-0031951182 (Pubitemid 28063408)
37. Zhang Y. Y., Li X., Qian S., Guo L., Huang H., He Q., Liu Y., Ma C., Tang Q., Down-regulation of type I Runx2 mediated by dexamethasone is required for 3T3-L1 adipogenesis. Molecular Endocrinology 2012 26 5 798 808 2-s2.0-84860344707 10.1210/me.2011-1287